Position in CRNX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,847,483
-$2,511,558 QoQ
Shares Held
133,466
-15.6% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.87136798885109.ToString("F0")%
None 2.1286320111489068.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. CRNX ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in CRNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,847,483 | 133,466 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $7,359,041 | 158,089 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,723,216 | 89,393 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,247,305 | 78,140 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,346,423 | 69,959 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,249,724 | 298,254 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,045,827 | 255,300 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,133,818 | 181,599 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,282,699 | 176,943 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,113,959 | 171,837 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,275,072 | 177,373 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $677,136 | 37,577 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $616,863 | 38,410 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $334,540 | 18,281 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $366,225 | 18,647 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $390,137 | 20,919 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $424,578 | 19,343 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,404,574 | 190,235 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $347,345 | 16,501 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $258,282 | 13,702 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||